Literature DB >> 19882646

Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.

Annie Dionne1, Michael W Nicolle, Angelika F Hahn.   

Abstract

Up to 16% of chronic inflammatory demyelinating polyneuropathy (CIDP) patients may present acutely. We performed a retrospective chart review on 30 acute inflammatory demyelinating polyneuropathy (AIDP) and 15 acute-onset CIDP (A-CIDP) patients looking for any clinical or electrophysiological parameters that might differentiate AIDP from acutely presenting CIDP. A-CIDP patients were significantly more likely to have prominent sensory signs. They were significantly less likely to have autonomic nervous system involvement, facial weakness, a preceding infectious illness, or need for mechanical ventilation. With regard to electrophysiological features, neither sural-sparing pattern, sensory ratio >1, nor the presence of A-waves was different between the two groups. This study suggests that patients presenting acutely with a demyelinating polyneuropathy and the aforementioned clinical features should be closely monitored as they may be more likely to have CIDP at follow-up.

Entities:  

Mesh:

Year:  2010        PMID: 19882646     DOI: 10.1002/mus.21480

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

Review 1.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

2.  The Diagnostic, Prognostic, and differential value of enhanced MR imaging in Guillain-Barre syndrome.

Authors:  H-F Li; X-J Ji
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-19       Impact factor: 3.825

3.  Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.

Authors:  Jia-Ying Sung; Jowy Tani; Susanna B Park; Matthew C Kiernan; Cindy Shin-Yi Lin
Journal:  Brain       Date:  2014-06-19       Impact factor: 13.501

4.  Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.

Authors:  Pierre R Bourque; J Brooks; J Warman-Chardon; A Breiner
Journal:  J Neurol       Date:  2019-11-16       Impact factor: 4.849

5.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

6.  A Rare case of recurrent Guillain-Barré syndrome without albuminocytological dissociation.

Authors:  Anudeep Yelam; Elanagan Nagarajan; Raghav Govindarajan; Pradeep C Bollu
Journal:  BMJ Case Rep       Date:  2018-10-16

Review 7.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

8.  Guillain-barré syndrome.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

9.  Vaccination-associated acute-onset chronic inflammatory demyelinating polyneuropathy followed by acute disseminated encephalomyelitis in a postpartum woman.

Authors:  Woojun Kim; Jae Young An
Journal:  Acta Neurol Belg       Date:  2020-08-18       Impact factor: 2.396

10.  Pediatric CIDP: Diagnosis and Management. A Single-Center Experience.

Authors:  Małgorzata Łukawska; Anna Potulska-Chromik; Marta Lipowska; Dorota Hoffman-Zacharska; Beata Olchowik; Magdalena Figlerowicz; Karolina Kanabus; Edyta Rosiak; Anna Kostera-Pruszczyk
Journal:  Front Neurol       Date:  2021-07-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.